Allergic bronchopulmonary aspergillosis is a pulmonary disease ... for ≥6 months off therapy with oral steroids 5a Treatment-dependent ABPA Two or more relapses within 6 months of stopping ...

Pulmonary aspergillosis presents with a variety of clinical forms including invasive pulmonary aspergillosis, chronic necrotising aspergillosis, aspergilloma, chronic cavitary pulmonary aspergillosis ...

Abecma’s review was delayed after the FDA rejected a first filing in May last year, but it’s hoped that the drug could be a significant step forward in the treatment of this incurable condition.

A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

It may respond to treatment with memantine or gabapentin. Isolated CN VI palsies (from fascicular damage in the brainstem) occur occasionally in MS, while CN III and CN IV palsies are seen very ...

are based on a more extensive database, with more than 30 years of additional rainfall data and data from extra rainfall stations; are more accurate estimates, combining contemporary statistical ...